PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer.
Crit Rev Oncol Hematol. 2020 Aug;152:102973. doi: 10.1016/j.critrevonc.2020.102973. Epub 2020 May 18.
Crit Rev Oncol Hematol. 2020.
PMID: 32497971
Free article.
Review.